Using inverse-weighting in cost-effectiveness analysis with censored data.
about
Median-based incremental cost-effectiveness ratios with censored dataClinical and cost-effectiveness analysis of an open label, single-centre, randomised trial of spinal cord stimulation (SCS) versus percutaneous myocardial laser revascularisation (PMR) in patients with refractory angina pectoris: The SPiRiT trial.Statistical analysis of cost-effectiveness data from randomized clinical trials.Cost-effectiveness of compression technologies for evidence-informed leg ulcer care: results from the Canadian Bandaging TrialSurvival analysis for economic evaluations alongside clinical trials--extrapolation with patient-level data: inconsistencies, limitations, and a practical guide.Cost effectiveness analysis of larval therapy for leg ulcers.The cost-effectiveness of the decision to hospitalize nursing home residents with advanced dementiaCost-effectiveness of initial stress cardiovascular MR, stress SPECT or stress echocardiography as a gate-keeper test, compared with upfront invasive coronary angiography in the investigation and management of patients with stable chest pain: mid-teStatistical considerations in economic evaluations: a guide for cardiologists.Nonparametric inference for time-dependent incremental cost-effectiveness ratios.EVALUATING COSTS WITH UNMEASURED CONFOUNDING: A SENSITIVITY ANALYSIS FOR THE TREATMENT EFFECT.Twice-weighted multiple interval estimation of a marginal structural model to analyze cost-effectiveness.
P2860
Q30958552-12223FF7-5CE2-4CA1-99E2-E4DEFE509CC6Q33347861-C193D322-0395-4B97-A80A-6EBCBFC514A1Q33596439-E58F3ED4-2206-4EB7-9409-22AA14C4F6E8Q34432229-8B6AFBE2-EAD6-4626-8055-114A5FA3F645Q34557762-30A6E597-4B62-4E28-A1E8-C2A23D007621Q34605671-DBC2FF8B-4BA8-4C63-9347-0A49E11A0E0DQ37004442-64E63B93-2895-4526-8ACB-C8DD838A6098Q37572029-319D46FE-C521-4030-916E-006C708D6A06Q38209728-14AC636B-42B5-4E6F-8A98-338AFCB6A032Q38980612-5AB48C16-5786-44D8-91ED-E180FF53E46AQ41979676-34452FDE-F128-4366-9F71-CDABCD51289AQ50143763-94FBEF52-D7F0-4833-879B-95E0DF6BFB1C
P2860
Using inverse-weighting in cost-effectiveness analysis with censored data.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Using inverse-weighting in cost-effectiveness analysis with censored data.
@ast
Using inverse-weighting in cost-effectiveness analysis with censored data.
@en
type
label
Using inverse-weighting in cost-effectiveness analysis with censored data.
@ast
Using inverse-weighting in cost-effectiveness analysis with censored data.
@en
prefLabel
Using inverse-weighting in cost-effectiveness analysis with censored data.
@ast
Using inverse-weighting in cost-effectiveness analysis with censored data.
@en
P2093
P2860
P1476
Using inverse-weighting in cost-effectiveness analysis with censored data.
@en
P2093
P2860
P304
P356
10.1191/0962280202SM308RA
P577
2002-12-01T00:00:00Z